A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 65, Issue 1, Pages 186-196
Publisher
Wiley
Online
2012-10-09
DOI
10.1002/art.37732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thyroglobulin Peptides Associate In Vivo to HLA-DR in Autoimmune Thyroid Glands
- (2014) L. Muixi et al. JOURNAL OF IMMUNOLOGY
- Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis
- (2012) Klemen Strle et al. ARTHRITIS AND RHEUMATISM
- Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy
- (2012) Linda K. Bockenstedt et al. JOURNAL OF CLINICAL INVESTIGATION
- Borrelia burgdorferi RST1 (OspC Type A) Genotype Is Associated with Greater Inflammation and More Severe Lyme Disease
- (2011) Klemen Strle et al. AMERICAN JOURNAL OF PATHOLOGY
- Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis
- (2011) Xin Li et al. ARTHRITIS AND RHEUMATISM
- Relationship between Immunity to Borrelia burgdorferi Outer-surface Protein A (OspA) and Lyme Arthritis
- (2011) Allen C. Steere et al. CLINICAL INFECTIOUS DISEASES
- The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function
- (2011) Jessica Herrath et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Genomics and the Multifactorial Nature of Human Autoimmune Disease
- (2011) Judy H. Cho et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms
- (2010) Abhishek Chandra et al. BRAIN BEHAVIOR AND IMMUNITY
- Complement Regulator–Acquiring Surface Protein 1 ofBorrelia burgdorferiBinds to Human Bone Morphogenic Protein 2, Several Extracellular Matrix Proteins, and Plasminogen
- (2010) Teresia Hallström et al. JOURNAL OF INFECTIOUS DISEASES
- Peptides Presented by HLA-DR Molecules in Synovia of Patients with Rheumatoid Arthritis or Antibiotic-Refractory Lyme Arthritis
- (2010) Robert J. Seward et al. MOLECULAR & CELLULAR PROTEOMICS
- Analysis ofBorrelia burgdorferigenotypes in patients with lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis
- (2009) Kathryn L. Jones et al. ARTHRITIS AND RHEUMATISM
- Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted from Central Nervous System of Multiple Sclerosis Patients
- (2009) Nicolas Fissolo et al. MOLECULAR & CELLULAR PROTEOMICS
- A Genome-Wide Proteome Array Reveals a Limited Set of Immunogens in Natural Infections of Humans and White-Footed Mice with Borrelia burgdorferi
- (2008) A. G. Barbour et al. INFECTION AND IMMUNITY
- Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis
- (2008) Elise E. Drouin et al. MOLECULAR IMMUNOLOGY
- A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
- (2008) Peng Wang et al. PLoS Computational Biology
- Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis
- (2007) Elise E. Drouin et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation